Your abstract should be informative, containing: (a) a sentence statement of the study's specific objectives, unless this is given in the title; (b) brief statement of methods, if pertinent; (c) summary of the results obtained; (d) statement of the conclusions. It is not satisfactory to state, "The results will be discussed."
Your abstract, including a concise, descriptive title, author(s), location where work was done, text and acknowledgment, may not exceed 250 words. Excessively long abstracts will be truncated.
The title should be all capital letters. Use significant words descriptive of subject content.
Authors' names start a new line.
The institution where your research was done should include city, state, and zip code. Do not include institutional subdivisions such as department.
The abstract should be one paragraph, single spaced, starting with a 3-space indentation.
Use standard abbreviations for common units of measure. Other words to be abbreviated, such as chemical names, should be spelled out in full for the first use, followed by the abbreviation in parenthesis. Do not abbreviate in the abstract title.
Use italics for scientific names of organisms.Begin authors' names on a new line. Place an asterisk (*) after the presenter(s), if there are multiple authors.
Use superscripts for institutional affiliations where necessary to avoid ambiguity.
Refer to these examples as guides.

EXAMPLES OF TITLES AND AUTHORS:

[single author, no ambiguity about designated speaker or affiliation]
AN EXPERIMENTAL MODEL FOR CHEMOTHERAPY ON DORMANT TUBERCULOUS INFECTION WITH PARTICULAR REFERENCE TO RIFAMPICIN
Joe E. Jones, Mississippi State University, Mississippi State, MS 39762
Abstract body starts here . . .

[two authors, one designated speaker, different affiliations, but no ambiguity]
AN EXPERIMENTAL MODEL FOR CHEMOTHERAPY ON DORMANT TUBERCULOUS INFECTION WITH PARTICULAR REFERENCE TO RIFAMPICIN
Joe E. Jones and Ralph A. Smith*, Mississippi State University, Mississippi State, MS 39762 and University of Mississippi Medical Center, Jackson, MS 39216
Abstract body starts here . . .

[two authors, both designated as speakers, different affiliations, but no ambiguity]
AN EXPERIMENTAL MODEL FOR CHEMOTHERAPY ON DORMANT TUBERCULOUS INFECTION WITH PARTICULAR REFERENCE TO RIFAMPICIN
Joe E. Jones* and Ralph A. Smith*, Mississippi State University, Mississippi State, MS 39762 and University of Mississippi Medical Center, Jackson, MS 39216
Abstract body starts here . . .

[three authors, one designated speaker, different affiliations]
AN EXPERIMENTAL MODEL FOR CHEMOTHERAPY ON DORMANT TUBERCULOUS INFECTION WITH PARTICULAR REFERENCE TO RIFAMPICIN
Joe E. Jones1, Ralph A. Smith1*, and Alice D. Doe2, 1Mississippi State University, Mississippi State, MS 39762 and 2University of Mississippi Medical Center, Jackson, MS 39216
Abstract body starts here . . .